Pathogenic role of mast cells in the development of diabetic nephropathy: A study of patients at different stages of the disease

Diabetologia

Volumn 55, Issue 3, 2012, Pages 801-811

  Zheng, J M ^a   Yao, G H ^a   Cheng, Z ^a   Wang, R ^a   Liu, Z H ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Chymase; Diabetic nephropathy; Fibrosis; Inflammation; Mast cells; Renin; TGF 1; TNF ; Tryptase

Indexed keywords

CHYMASE; RENIN; TRANSFORMING GROWTH FACTOR BETA1; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL COUNT; CELLULAR DISTRIBUTION; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETIC NEPHROPATHY; DISEASE COURSE; ENZYME RELEASE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; KIDNEY BIOPSY; KIDNEY INTERSTITIUM; KIDNEY TUBULE DAMAGE; MAJOR CLINICAL STUDY; MALE; MAST CELL; MAST CELL DEGRANULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ADULT; ALBUMINURIA; CELL COUNT; CELL DEGRANULATION; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; FIBROSIS; HUMANS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY TUBULES; MALE; MAST CELLS; MIDDLE AGED; PROTEINURIA; RENAL INSUFFICIENCY; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84856696754     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2391-2     Document Type: Article

References (50)

1. P Balakumar MK Arora SS Ganti J Reddy M Singh 2009 Recent advances in pharmacotherapy for diabetic nephropathy: current perspectives and future directions Pharmacol Res 60 24 32 19427582 10.1016/j.phrs.2009.02.002 1:CAS:528:DC%2BD1MXlslWlu74%3D
2. T Kawakami 2009 A crucial door to the mast cell mystery knocked in J Immunol 18 6863 6881
3. SJ Galli J Kalesnikoff MA Grimbaldeston AM Piliponsky CM Williams M Tsai 2005 Mast cells as "tunable" effector and immunoregulatory cells: recent advances Annu Rev Immunol 23 749 786 15771585 10.1146/annurev.immunol.21. 120601.141025 1:CAS:528:DC%2BD2MXktFOju70%3D
4. W Dawicki JS Marshall 2007 New and emerging roles for mast cells in host defence Curr Opin Immunol 19 31 38 17126541 10.1016/j.coi.2006.11.006 1:CAS:528:DC%2BD2sXmtVeltA%3D%3D
5. BA Sayed A Christy MR Quirion MA Brown 2008 The master switch: the role of mast cells in autoimmunity and tolerance Annu Rev Immunol 26 705 739 18370925 10.1146/annurev.immunol.26.021607.090320 1:CAS:528:DC%2BD1cXltlWktrc%3D
6. R Malaviya SN Abraham 2001 Mast cell modulation of immune responses to bacteria Immunol Rev 179 16 24 11292019 10.1034/j.1600-065X.2001.790102.x 1:STN:280:DC%2BD3MvgvVyntg%3D%3D
7. SJ Galli S Nakae M Tsai 2005 Mast cells in the development of adaptive immune responses Nat Immunol 6 135 142 15662442 10.1038/ni1158 1:CAS:528:DC%2BD2MXlvVKmsA%3D%3D
8. SP Levick JL McLarty DB Murray RM Freeman WE Carver GL Brower 2009 Cardiac mast cells mediate left ventricular fibrosis in the hypertensive rat heart Hypertension 53 1041 1047 19398662 10.1161/HYPERTENSIONAHA.108.123158 1:CAS:528:DC%2BD1MXlslCiurY%3D
9. T Sakamoto-Ihara Y Suzuki A Kurusu M Yamashita S Horikoshi Y Tomino 2007 Possible involvement of mast cells in renal fibrosis in patients with IgA nephropathy Inflamm Res 56 421 427 18026699 10.1007/s00011-007-6145-z 1:CAS:528:DC%2BD2sXht1KmsLrO
10. RM Melillo V Guarino E Avilla, et al. 2010 Mast cells have a protumorigenic role in human thyroid cancer Oncogene 29 6203 6215 20729915 10.1038/onc.2010.348 1:CAS:528:DC%2BC3cXhtVGgtLnJ
11. BM Rüger Q Hasan NS Greenhill PF Davis PR Dunbar TJ Neale 1996 Mast cells and type VIII collagen in human diabetic nephropathy Diabetologia 39 1215 1222 8897010 10.1007/BF02658509
12. K Hiromura M Kurosawa S Yano T Naruse 1998 Tubulointerstitial mast cell infiltration in glomerulonephritis Am J Kidney Dis 32 593 599 9774120 10.1016/S0272-6386(98)70022-8 1:STN:280:DyaK1cvksFWjtg%3D%3D
13. IS Roberts PE Brenchley 2000 Mast cells: the forgotten cells of renal fibrosis J Clin Pathol 53 858 862 11127270 10.1136/jcp.53.11.858 1:STN:280:DC%2BD3M7gsVaisw%3D%3D
14. S Kondo S Kagami H Kido F Strutz GA Müller Y Kuroda 2001 Role of mast cell tryptase in renal interstitial fibrosis J Am Soc Nephrol 12 1668 1676 11461939 1:CAS:528:DC%2BD3MXlvVCku70%3D
15. E Goto S Honjo H Yamashita K Shomori H Adachi H Ito 2002 Mast cells in human allografted kidney: correlation with interstitial fibrosis Clin Transplant 16 Suppl 8 7 11 12464125 10.1034/j.1399-0012.16.s8.1.x
16. T Ehara H Shigematsu 2003 Mast cells in the kidney Nephrology (Carlton) 8 130 138 10.1046/j.1440-1797.2003.00153.x 1:CAS:528:DC%2BD3sXlsFert7g%3D
17. K Okon J Stachura 2007 Increased mast cell density in renal interstitium is correlated with relative interstitial volume, serum creatinine and urea especially in diabetic nephropathy but also in primary glomerulonephritis Pol J Pathol 58 193 197 18074865
18. SR Holdsworth SA Summers 2008 Role of mast cells in progressive renal diseases J Am Soc Nephrol 19 2254 2261 18776124 10.1681/ASN.2008010015 1:CAS:528:DC%2BD1MXlvF2hsQ%3D%3D
19. P Welker S Krämer DA Groneberg, et al. 2008 Increased mast cell number in human hypertensive nephropathy Am J Physiol Renal Physiol 295 F1103 F1109 18684889 10.1152/ajprenal.00374.2007 1:CAS:528:DC%2BD1cXht1ymu77J
20. GE Silva RS Costa RC Ravinal MA dos Reis M Dantas TM Coimbra 2008 Mast cells, TGF-beta1 and alpha-SMA expression in IgA nephropathy Dis Markers 24 181 190 18334740 1:CAS:528:DC%2BD1cXislanu74%3D
21. P Balakumar J Reddy M Singh 2009 Do resident renal mast cells play a role in the pathogenesis of diabetic nephropathy? Mol Cell Biochem 330 187 192 19415459 10.1007/s11010-009-0132-3 1:CAS:528:DC%2BD1MXhtlCqurjJ
22. H Togawa K Nakanishi Y Shima, et al. 2009 Increased chymase-positive mast cells in children with crescentic glomerulonephritis Pediatr Nephrol 24 1071 1075 19050935 10.1007/s00467-008-1044-2
23. TW Tervaert AL Mooyaart K Amann, et al. 2010 Pathologic classification of diabetic nephropathy J Am Soc Nephrol 21 556 563 20167701 10.1681/ASN. 2010010010
24. K Okon A Szumera M Kuzniewski 2003 Are CD34+ cells found in renal interstitial fibrosis? Am J Nephrol 23 409 414 14566107 10.1159/000074298
25. LK Singh W Boucher X Pang, et al. 1999 Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors J Pharmacol Exp Ther 288 1349 1156 10027877 1:CAS:528:DyaK1MXhs1KisLs%3D
26. M Metz MA Grimbaldeston S Nakae AM Piliponsky M Tsai SJ Galli 2007 Mast cells in the promotion and limitation of chronic inflammation Immunol Rev 217 304 328 17498068 10.1111/j.1600-065X.2007.00520.x 1:CAS:528:DC%2BD2sXnt1Gmu7s%3D
27. S Nakae H Suto GJ Berry SJ Galli 2007 Mast cell-derived TNF can promote Th17 cell-dependent neutrophil recruitment in ovalbumin-challenged OTII mice Blood 109 3640 3648 17197430 10.1182/blood-2006-09-046128 1:CAS:528: DC%2BD2sXkvFCitr0%3D
28. MA Grimbaldeston S Nakae J Kalesnikoff M Tsai SJ Galli 2007 Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B Nat Immunol 8 1095 1104 17767162 10.1038/ni1503 1:CAS:528:DC%2BD2sXhtVCkurnL
29. TC Moon CD St Laurent KE Morris, et al. 2010 Advances in mast cell biology: new understanding of heterogeneity and function Mucosal Immunol 3 111 128 20043008 10.1038/mi.2009.136 1:CAS:528:DC%2BC3cXhvVGqurk%3D
30. RB Silver AC Reid CJ Mackins, et al. 2004 Mast cells: a unique source of renin Proc Natl Acad Sci USA 101 13607 13612 15342908 10.1073/pnas.0403208101 1:CAS:528:DC%2BD2cXnvFehs74%3D
31. S Helske S Syväranta M Kupari, et al. 2006 Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves Eur Heart J 27 1495 1504 16401677 10.1093/eurheartj/ehi706 1:CAS:528: DC%2BD28Xnt1Giu7s%3D
32. T Ehara H Shigematsu 1998 Contribution of mast cells to the tubulointerstitial lesions in IgA nephritis Kidney Int 54 1675 1683 9844144 10.1046/j.1523-1755.1998.00159.x 1:CAS:528:DyaK1cXnsVeqtbs%3D
33. T Tóth R Tóth-Jakatics S Jimi S Takebayashi 2000 Increased density of interstitial mast cells in amyloid A renal amyloidosis Mod Pathol 13 1020 1028 11007043 10.1038/modpathol.3880184
34. M Yamada M Ueda T Naruko, et al. 2001 Mast cell chymase expression and mast cell phenotypes in human rejected kidneys Kidney Int 59 1374 1381 11260398 10.1046/j.1523-1755.2001.0590041374.x 1:CAS:528:DC%2BD3MXjtVOhtL0%3D
35. G Nilsson M Johnell CH Hammer, et al. 1996 C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway J Immunol 157 1693 1698 8759757 1:CAS:528:DyaK28XkvFWgs7g%3D
36. K Hartmann BM Henz S Krüger-Krasagakes, et al. 1997 C3a and C5a stimulate chemotaxis of human mast cells Blood 89 2863 2870 9108406 1:CAS:528:DyaK2sXisFChs7k%3D
37. TK Hansen C Forsblom M Saraheimo, et al. 2010 Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes Diabetologia 53 1517 1524 20396997 10.1007/s00125-010-1742-8 1:CAS:528:DC%2BC3cXmsFyrsLo%3D
38. AM Irani SS Craig G DeBlois CO Elson NM Schechter LB Schwartz 1987 Deficiency of the tryptase positive, chymase negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function J Immunol 138 4381 4386 3295046 1:STN:280:DyaL2s3isVWjuw%3D%3D
39. S Chen B Jim FN Ziyadeh 2003 Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up Semin Nephrol 23 532 543 14631561 10.1053/S0270-9295(03)00132-3 1:CAS:528:DC%2BD2cXisVWl
40. WA Border NA Noble 1997 TGF-beta in kidney fibrosis: a target for gene therapy Kidney Int 51 1388 1396 9150449 10.1038/ki.1997.190 1:CAS:528: DyaK2sXjsFShtrg%3D
41. WA Border NA Noble 1998 Evidence that TGF-beta should be a therapeutic target in diabetic nephropathy Kidney Int 54 1390 1391 9773681 10.1046/j.1523-1755.1998.00127.x 1:STN:280:DyaK1cvksVKltg%3D%3D
42. K Sharma Y Jin J Guo FN Ziyadeh 1996 Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice Diabetes 45 522 530 8603776 10.2337/diabetes.45.4.522 1:CAS:528:DyaK28Xjs1Gjuro%3D
43. Y Huang NA Noble J Zhang C Xu WA Border 2007 Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells Kidney Int 72 45 52 17396111 10.1038/sj.ki.5002243 1:CAS:528: DC%2BD2sXntVCjtL0%3D
44. M He L Zhang Y Shao, et al. 2009 Inhibition of renin/prorenin receptor attenuated mesangial cell proliferation and reduced associated fibrotic factor release Eur J Pharmacol 606 155 161 19174157 10.1016/j.ejphar.2008.12.050 1:CAS:528:DC%2BD1MXivVehtrs%3D
45. P Balakumar G Jagadeesh 2010 Cardiovascular and renal pathologic implications of prorenin, renin, and the (pro)renin receptor: promising young players from the old renin-angiotensin-aldosterone system J Cardiovasc Pharmacol 56 570 579 21108514 10.1097/FJC.0b013e3181f21576 1:CAS:528:DC%2BC3cXhtl2gurrE
46. DJ Kelly Y Zhang G Moe G Naik RE Gilbert 2007 Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats Diabetologia 50 2398 2404 17828524 10.1007/s00125-007-0795-9 1:CAS:528:DC%2BD2sXhtFSlsL%2FI
47. MH Holtmann MF Neurath 2004 Differential TNF-signaling in chronic inflammatory disorders Curr Mol Med 4 439 444 15354874 10.2174/1566524043360636 1:CAS:528:DC%2BD2cXksFGjt7g%3D
48. MG Matera L Calzetta M Cazzola 2010 TNF-alpha inhibitors in asthma and COPD: we must not throw the baby out with the bath water Pulm Pharmacol Ther 23 121 128 19853667 10.1016/j.pupt.2009.10.007 1:CAS:528:DC%2BC3cXhs1yitrw%3D
49. N Koike T Takamura S Kaneko 2007 Induction of reactive oxygen species from isolated rat glomeruli by protein kinase C activation and TNF-alpha stimulation, and effects of a phosphodiesterase inhibitor Life Sci 80 1721 1728 17346751 10.1016/j.lfs.2007.02.001 1:CAS:528:DC%2BD2sXjsVCjsbo%3D
50. SE Jones DJ Kelly AJ Cox Y Zhang RM Gow RE Gilbert 2003 Mast cell infiltration and chemokine expression in progressive renal disease Kidney Int 64 906 913 12911540 10.1046/j.1523-1755.2003.00183.x 1:CAS:528: DC%2BD3sXntl2mtbY%3D